Shares of The Clorox Company (NYSE:CLX - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $126.40 and last traded at $126.81, with a volume of 171973 shares. The stock had previously closed at $127.69.
Analysts Set New Price Targets
A number of brokerages have weighed in on CLX. UBS Group reduced their price target on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Wells Fargo & Company reduced their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Evercore ISI set a $140.00 target price on Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. JPMorgan Chase & Co. cut their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. Finally, Citigroup decreased their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $151.23.
Check Out Our Latest Stock Report on Clorox
Clorox Stock Up 0.2%
The stock has a market capitalization of $15.77 billion, a P/E ratio of 34.95, a P/E/G ratio of 2.62 and a beta of 0.54. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm's fifty day moving average is $136.60 and its 200-day moving average is $149.66.
Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business's revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.71 EPS. As a group, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.
Insider Transactions at Clorox
In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.57% of the company's stock.
Hedge Funds Weigh In On Clorox
Institutional investors have recently modified their holdings of the stock. Redwood Park Advisors LLC acquired a new stake in shares of Clorox during the 4th quarter worth approximately $26,000. Millstone Evans Group LLC acquired a new position in shares of Clorox during the fourth quarter worth about $31,000. Wood Tarver Financial Group LLC acquired a new position in Clorox during the fourth quarter worth $31,000. Asset Planning Inc bought a new stake in Clorox during the fourth quarter worth about $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in Clorox during the fourth quarter worth $32,000. 78.53% of the stock is owned by institutional investors.
About Clorox
(
Get Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
